Skip to main content
OpenTrials

Clinical trial condition

Multidrug Resistant Tuberculosis

Explore clinical trials studying Multidrug Resistant Tuberculosis. Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Multidrug Resistant Tuberculosis trial results

Recruiting

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

NCT05081401

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations
  • Guiyang Public Health Treatment Center Guiyang, Guizhou, China
  • People's Hospital of Qiandongnan Kaili, Guizhou, China
  • The Third People's Hospital of Liupanshui Liupanshui, Guizhou, China
  • Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China
View Trial Details
Completed

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

NCT03867136

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • The Third People's Hospital of Shenzhen City Shenzhen, Guangzhou, China
  • Guiyang Public Health Treatment Center Guizhou, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Hunan Chest Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Completed

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

NCT04717908

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • The Third People's Hospital of Shenzhen City Shenzhen, Guangzhou, China
  • Guiyang Public Health Treatment Center Guizhou, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Hunan Chest Hospital Changsha, Hunan, China
View all 15 locations
View Trial Details
Completed

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

NCT03942354

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital Minsk, Belarus
  • THINK Clinical Trial Unit, Hillcrest Durban, KwaZulu-Natal, South Africa
  • Doris Goodwin Hospital Pietermaritzburg, KwaZulu-Natal, South Africa
  • Helen Jospeh Hospital Johannesburg, South Africa
View Trial Details
Completed

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

NCT01859923

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations
  • De La Salle Health Sciences Institute Dasmariñas, Cavite, Philippines
  • Lung Center of the Philippines Quezon City, National Capital Region, Philippines
  • Brooklyn Chest Hospital Ysterplaat, Cape Town, South Africa
View Trial Details

Related conditions